Morari Medical Releases FDA-Cleared MOR Patch

Morari Medical unveiled the FDA-cleared MOR patch at CES 2026; the adhesive perineal device delivers mild electrical stimulation and is available immediately for $299. The company says the clearance covers safety only, not clinical proof for treating sexual dysfunction, and the patch pairs with a Bluetooth smartphone app (data recording defaults to opt-out), positioning it as a consumer sex-toy.
Key Points
- 1Announces FDA-cleared adhesive MOR patch delivering mild electrical stimulation for the perineum, priced at $299
- 2Highlights safety-only approval; no clinical evidence supports sexual-dysfunction treatment claims, limiting medical positioning
- 3Implies product adoption will target consumer sex-toy market; practitioners should not assume therapeutic efficacy
Scoring Rationale
New FDA-cleared consumer device with immediate availability; limited novelty and narrow relevance outside sexual-health niche.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems